Your browser doesn't support javascript.
loading
In response to the Letter to the Editor by Romach et al. re our publication "Dolutegravir in pregnant mice is associated with increased rates of fetal defects at therapeutic but not at supratherapeutic levels".
Mohan, H; Guzman Lenis, M; Laurette, E Y; Tejada, O; Sanghvi, T; Leung, K-Y; Cahill, L S; Sled, J G; Delgado-Olguín, P; Greene, N D E; Copp, A J; Serghides, L.
Affiliation
  • Mohan H; Toronto General Hospital Research Institute, University Health Network, Toronto, Canada.
  • Guzman Lenis M; Toronto General Hospital Research Institute, University Health Network, Toronto, Canada.
  • Laurette EY; Toronto General Hospital Research Institute, University Health Network, Toronto, Canada.
  • Tejada O; Toronto General Hospital Research Institute, University Health Network, Toronto, Canada.
  • Sanghvi T; Toronto General Hospital Research Institute, University Health Network, Toronto, Canada.
  • Leung KY; Developmental Biology & Cancer Department, UCL Great Ormond Street Institute of Child Health, University College London, London, UK.
  • Cahill LS; Mouse Imaging Centre, The Hospital for Sick Children, Toronto, Ontario, Canada; Department of Chemistry, Memorial University of Newfoundland, St John's, Newfoundland and Labrador, Canada.
  • Sled JG; Mouse Imaging Centre, The Hospital for Sick Children, Toronto, Ontario, Canada; Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada; Translational Medicine, The Hospital for Sick Children, Toronto, Ontario M5G 0A4, Canada.
  • Delgado-Olguín P; Translational Medicine, The Hospital for Sick Children, Toronto, Ontario M5G 0A4, Canada; Department of Molecular Genetics, University of Toronto, Toronto, Ontario M5S 1A8, Canada; Heart & Stroke Richard Lewar Centre of Excellence, Toronto, Ontario M5S 3H2, Canada.
  • Greene NDE; Developmental Biology & Cancer Department, UCL Great Ormond Street Institute of Child Health, University College London, London, UK.
  • Copp AJ; Developmental Biology & Cancer Department, UCL Great Ormond Street Institute of Child Health, University College London, London, UK.
  • Serghides L; Toronto General Hospital Research Institute, University Health Network, Toronto, Canada; Department of Immunology and Institute of Medical Sciences, University of Toronto, Toronto, Ontario, Canada; Women's College Research Institute, Women's College Hospital, Toronto, Ontario, Canada. Electronic add
EBioMedicine ; 66: 103334, 2021 04.
Article in En | MEDLINE | ID: mdl-33862586

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Fetus / Heterocyclic Compounds, 3-Ring Type of study: Risk_factors_studies Limits: Animals / Pregnancy Language: En Journal: EBioMedicine Year: 2021 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Fetus / Heterocyclic Compounds, 3-Ring Type of study: Risk_factors_studies Limits: Animals / Pregnancy Language: En Journal: EBioMedicine Year: 2021 Document type: Article Affiliation country: Country of publication: